celecoxib has been researched along with Hypopharyngeal Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sterzik, A | 1 |
| Paprottka, PM | 2 |
| Zengel, P | 2 |
| Hirner, H | 1 |
| Roßpunt, S | 2 |
| Eschbach, R | 1 |
| Moser, M | 1 |
| Havla, L | 1 |
| Ingrisch, M | 2 |
| Mack, B | 2 |
| Reiser, MF | 2 |
| Nikolaou, K | 2 |
| Cyran, CC | 2 |
| Gires, O | 1 |
| Clevert, DA | 1 |
| Zhang, X | 1 |
| Chen, ZG | 1 |
| Choe, MS | 1 |
| Lin, Y | 1 |
| Sun, SY | 1 |
| Wieand, HS | 1 |
| Shin, HJ | 1 |
| Chen, A | 1 |
| Khuri, FR | 1 |
| Shin, DM | 1 |
3 other studies available for celecoxib and Hypopharyngeal Cancer
| Article | Year |
|---|---|
DCE-MRI biomarkers for monitoring an anti-angiogenic triple combination therapy in experimental hypopharynx carcinoma xenografts with immunohistochemical validation.
Topics: Angiogenesis Inhibitors; Animals; Biomarkers, Tumor; Carcinoma, Squamous Cell; Celecoxib; Combined M | 2015 |
Reducing tumor growth and angiogenesis using a triple therapy measured with Contrast-enhanced ultrasound (CEUS).
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cell Line, Tumor; Cell Prolifera | 2015 |
Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Celecoxib; Cyclooxygenase 2; Cyclooxygenas | 2005 |